Journal List > Korean J Gastroenterol > v.72(3) > 1101288

Choi, Kim, Kim, Lee, Shin, Kim, Choi, Choi, Chung, and Kwon: Primary Hepatic Schwannoma

Abstract

A primary benign schwannoma of the liver is extremely rare. Only 30 cases have been reported in the medical literature worldwide, and only one case has been reported in Korea previously. A 56-year-old man was admitted to Gil Medical Center with incidental findings of a hepatic mass by abdominal computed tomography. The computed tomography and magnetic resonance image revealed a 3×2 cm-sized solid mass in the left lobe of the liver. Histological examination confirmed the diagnosis of a benign schwannoma, proven by positive immunoreaction with the neurogenic marker S-100 protein and a negative response to CD34, CD117, and smooth muscle actin. We report a primary benign schwannoma of the liver and review the literature.

References

1. Albert P, Patel J, Badawy K, et al. Peripheral nerve schwannoma: a review of varying clinical presentations and imaging findings. J Foot Ankle Surg. 2017; 56:632–637.
crossref
2. Yamamoto M, Hasegawa K, Arita J, et al. Primary hepatic schwannoma: a case report. Int J Surg Case Rep. 2016; 29:146–150.
crossref
3. Jung HI, Lee HU, Ahn TS, et al. Primary hepatic malignant peripheral nerve sheath tumor successfully treated with combination therapy: a case report and literature review. Ann Surg Treat Res. 2016; 91:327–331.
crossref
4. Yin SY, Zhai ZL, Ren KW, et al. Porta hepatic schwannoma: case report and a 30-year review of the literature yielding 15 cases. World J Surg Oncol. 2016; 14:103.
crossref
5. Momtahen AJ, Akduman EI, Balci NC, Fattahi R, Havlioglu N. Liver schwannoma: findings on MRI. Magn Reson Imaging. 2008; 26:1442–1445.
crossref
6. Young SJ. Primary malignant neurilemmoma (schwannoma) of the liver in a case of neurofibromatosis. J Pathol. 1975; 117:151–153.
crossref
7. Lee WH, Kim TH, You SS, et al. Benign schwannoma of the liver: a case report. J Korean Med Sci. 2008; 23:727–730.
crossref
8. Shih YC, Chen YL, Fang HY, Wu CY, Lin YC, Lin YM. Schwannoma mimicking liver tumor. Thorac Cardiovasc Surg. 2009; 57:436–439.
crossref
9. Ozkan EE, Guldur ME, Uzunkoy A. A case report of benign schwannoma of the liver. Intern Med. 2010; 49:1533–1536.
crossref
10. Madhusudhan KS, Srivastava DN, Dash NR, Gupta C, Gupta SD. Case report. Schwannoma of both intrahepatic and extrahepatic bile ducts: a rare case. Br J Radiol. 2009; 82:e212–e215.
11. Kulkarni N, Andrews SJ, Rao V, Rajagopal KV. Case report: benign porta hepatic schwannoma. Indian J Radiol Imaging. 2009; 19:213–215.
crossref
12. Yoshida M, Nakashima Y, Tanaka A, Mori K, Yamaoka Y. Benign schwannoma of the liver: a case report. Nihon Geka Hokan. 1994; 63:208–214.
13. Kim YC, Park MS. Primary hepatic schwannoma mimicking malignancy on fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography. Hepatology. 2010; 51:1080–1081.
crossref
14. Hayashi M, Takeshita A, Yamamoto K, Tanigawa N. Primary hepatic benign schwannoma. World J Gastrointest Surg. 2012; 4:73–78.
crossref
15. Ota Y, Aso K, Watanabe K, et al. Hepatic schwannoma: imaging findings on CT, MRI and contrastenhanced ultrasonography. World J Gastroenterol. 2012; 18:4967–4972.
crossref
16. Lederman SM, Martin EC, Laffey KT, Lefkowitch JH. Hepatic neurofibromatosis, malignant schwannoma, and angiosarcoma in von Recklinghausen's disease. Gastroenterology. 1987; 92:234–239.
crossref
17. Heffron TG, Coventry S, Bedendo F, Baker A. Resection of primary schwannoma of the liver not associated with neurofibromatosis. Arch Surg. 1993; 128:1396–1398.
crossref
18. Godlewski G, Sawan S, Targhetta P, Pignodel C, Marty-Double C, Gaujoux AF. A malignant schwannoma of the jejunum associated with multiple neurofibromas and a primary adenoma of the parathyroid. Ann Gastroenterol Hepatol (Paris). 1989; 25:13–17.
19. Ikehara H, Li Z, Watari J, et al. Histological diagnosis of gastric submucosal tumors: a pilot study of endoscopic ultrasonography-guided fine-needle aspiration biopsy vs mucosal cutting biopsy. World J Gastrointest Endosc. 2015; 7:1142–1149.
crossref
20. Harwalkar JA, Lee JH, Hughes G, Kinney SE, Golubić M. Immunoblotting analysis of schwannomin/merlin in human schwannomas. Am J Otol. 1998; 19:654–659.

Fig. 1.
Abdominal ultrasonography (US). US revealed an about 3 cm-sized, low echoic mass with homogeneous pattern in the left lobe of the liver.
kjg-72-150f1.tif
Fig. 2.
Dynamic abdominal computed tomography (CT). (A) Arterial phase (arrow), (B) portal phase (arrow), (C) venous phase: CT showed a well-defined, rounded (arrow), low-attenuating mass with homogeneous attenuation in the left lobe of the liver.
kjg-72-150f2.tif
Fig. 3.
Liver magnetic resonance imaging. (A) T1-WI. A 35 mm suspicious enhancing lesion (white arrow) in the left liver: a mass that is mildly hypointense or isointense on non-contrasted T1-WI. (B) T2-WI. Lesion (white arrow) was heterogeneously hyperintense. (C) Hepatobiliary phase. Gadoxetic-acid enhanced heaptobiliary phase images show hypointense lesion (white arrow). WI, weighted image.
kjg-72-150f3.tif
Fig. 4.
Histologic examination. (A) The sections show a moderately cellular schwannoma. Mitoses are inconspicuous (H&E, ×200). (B) The tumor is composed of bundles of compact spindle cells that are immunoreactive to S-100 protein, brown particles (immunohistochemical stain, ×200).
kjg-72-150f4.tif
Table 1.
Summary of Clinicopathological Data from 30 Cases of Hepatic Schwannoma
  Value
Mean follow up (months) 14.6±2.7
Age (years) 50.8±15.7
Male 19 (63.3)
Symptoms  
   Asymptomatic 9 (30.0)
   Symptomatic 21 (70.0)
      Anorexia, Nausea, Vomiting 0 (0)
      Abdominal discomfort 20 (66.5)
      Jaundice 1 (3.4)
      Weight loss 0 (0)
Primary diagnosis  
   Schwannoma 3 (10.0)
   Malignant liver tumor (adenoma, HCC) 8 (26.7)
   Benign liver tumor (cyst, liver hydatid cyst, 5 (16.7)
   hematoma)  
   Intrahepatic cholangiocarcinoma 4 (13.3)
   Metastatic cancer 2 (6.7)
   Mesenchymal tumor (GIST, myxoid liposarcoma, 8 (26.7)
   hepatosarcoma, spindle tumor)  
Tumor size (cm) 12.0±8.5
Single 27 (90)
Location  
   Right lobe 13 (43.3)
   Left lobe 14 (46.7)
   Both 3 (10.0)
Pathology  
   Benign 21 (70.0)
   Malignant 9 (30.0)
Treatment  
   Surgery 25 (83.3)
   TACE 2 (6.7)
   Untreated 3 (10.0)
Outcome  
   Survival 24 (80.0)
   Death 6 (20.0)

Values are presented as mean±standard deviation or n (%).

HCC, hepatocelullar carcinoma; GIST, gastrointestinal stromal tumors; TACE, transcatheter arterial chemoembolization.

TOOLS
ORCID iDs

Ju Hyun Kim
https://orcid.org/0000-0001-8981-135X

Similar articles